Histone hyperacetylation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts
- PMID: 11304533
- DOI: 10.1074/jbc.M100206200
Histone hyperacetylation induced by histone deacetylase inhibitors is not sufficient to cause growth inhibition in human dermal fibroblasts
Abstract
Use of specific histone deacetylase inhibitors has revealed critical roles for the histone deacetylases (HDAC) in controlling proliferation. Although many studies have correlated the function of HDAC inhibitors with the hyperacetylation of histones, few studies have specifically addressed whether the accumulation of acetylated histones, caused by HDAC inhibitor treatment, is responsible for growth inhibition. In the present study we show that HDAC inhibitors cause growth inhibition in normal and transformed keratinocytes but not in normal dermal fibroblasts. This was despite the observation that the HDAC inhibitor, suberic bishydroxamate (SBHA), caused a kinetically similar accumulation of hyperacetylated histones. This cell type-specific response to SBHA was not due to the inactivation of SBHA by fibroblasts, nor was it due to differences in the expression of specific HDAC family members. Remarkably, overexpression of HDACs 1, 4, and 6 in normal human fibroblasts resulted in cells that could be growth-inhibited by SBHA. These data suggest that, although histone acetylation is a major target for HDAC inhibitors, the accumulation of hyperacetylated histones is not sufficient to cause growth inhibition in all cell types. This suggests that growth inhibition, caused by HDAC inhibitors, may be the culmination of histone hyperacetylation acting in concert with other growth regulatory pathways.
Similar articles
-
Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts.Br J Dermatol. 2007 Oct;157(4):662-9. doi: 10.1111/j.1365-2133.2007.08122.x. Epub 2007 Aug 17. Br J Dermatol. 2007. PMID: 17711521
-
Histone deacetylase inhibitors selectively suppress expression of HDAC7.Mol Cancer Ther. 2007 Sep;6(9):2525-34. doi: 10.1158/1535-7163.MCT-07-0251. Mol Cancer Ther. 2007. PMID: 17876049
-
Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.Arthritis Rheum. 2005 Jan;52(1):94-104. doi: 10.1002/art.20714. Arthritis Rheum. 2005. PMID: 15641079
-
The histone deacetylase inhibitor suberic bishydroxamate: a potential sensitizer of melanoma to TNF-related apoptosis-inducing ligand (TRAIL) induced apoptosis.Biochem Pharmacol. 2003 Oct 15;66(8):1537-45. doi: 10.1016/s0006-2952(03)00509-4. Biochem Pharmacol. 2003. PMID: 14555232 Review.
-
Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics.Mol Cancer Ther. 2008 Apr;7(4):740-8. doi: 10.1158/1535-7163.MCT-07-2284. Mol Cancer Ther. 2008. PMID: 18413789 Review.
Cited by
-
Dietary manipulation of histone structure and function.J Nutrigenet Nutrigenomics. 2010;3(4-6):231-8. doi: 10.1159/000324359. Epub 2011 Apr 6. J Nutrigenet Nutrigenomics. 2010. PMID: 21474954 Free PMC article. No abstract available.
-
Impact of Epigenetic Dietary Components on Cancer through Histone Modifications.Curr Med Chem. 2015;22(17):2051-64. doi: 10.2174/0929867322666150420102641. Curr Med Chem. 2015. PMID: 25891109 Free PMC article. Review.
-
Bim upregulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL, and Mcl-1.Mol Cell Biol. 2009 Dec;29(23):6149-69. doi: 10.1128/MCB.01481-08. Epub 2009 Oct 5. Mol Cell Biol. 2009. PMID: 19805519 Free PMC article.
-
Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention.J Nutr. 2009 Dec;139(12):2393-6. doi: 10.3945/jn.109.113332. Epub 2009 Oct 7. J Nutr. 2009. PMID: 19812222 Free PMC article.
-
BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer.EBioMedicine. 2017 Jun;20:50-60. doi: 10.1016/j.ebiom.2017.05.001. Epub 2017 May 4. EBioMedicine. 2017. PMID: 28501528 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources